Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Clovis Oncology Inc (CLVS)

59.14 -1.78 (-2.92%)

2/28/2017  11:41am

Open:

60.40

Pre. Close:

60.92

High:

60.50

Low:

57.89

Volume:

867,976

Market Cap:

2.28B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

62.27 - 62.99

62.99 - 63.76

Low:

55.4 - 56.12

56.12 - 56.87

Close:

59.57 - 61.13

61.13 - 62.77

Technical analysis  (as of: 2017-02-28 11:39:59 AM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 73.71     One year: 78.44

Support:

Support1: 56.56    Support2: 47.06

Resistance:

Resistance1: 63.11    Resistance2: 67.16

Pivot:

61.74

Moving Averages:

MA(5): 59.45     MA(20): 62.34

MA(100): 44.25     MA(250): 28.80

MACD:

MACD(12,26): 1.13     Signal(12,26,9): 2.19

%K %D:

%K(14,3): 28.96     %D(3): 22.91

RSI:

RSI(14): 49.86

52-Week:

High: 67.16  Low: 11.57  Change(%): 184.2

Average Vol(K):

3-Month: 2354  10-Days 1712

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
CLVS has closed above bottom band by 25.3%. Bollinger Bands are 15.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 27 Feb 2017 22:30:00 GMT
Clovis Oncology Inc. (CLVS) Soars 5.22% on February 27

Thu, 23 Feb 2017 17:48:45 GMT
Commit To Purchase Clovis Oncology At $35, Earn 12.3% Using Options

Tue, 14 Feb 2017 17:51:08 GMT
Update in Lawsuit for Investors in shares of Clovis Oncology Inc (NASDAQ:CLVS ...

Sun, 19 Feb 2017 01:41:15 GMT
Johnson & Weaver, LLP Announces Investigations of Clovis Oncology, Inc., USANA ...

Thu, 09 Feb 2017 23:11:37 GMT
Clovis Oncology to Announce Fourth Quarter/Year-End 2016 Financial Results and ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

44.33

Shares Float (M)

26.74

% Held by Insiders

10.02

% Held by Institutions

84.30

Shares Short (K)

7270

Shares Short Prior Month (K)

7440

Stock Financials

EPS

-10.360

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

1.480

PEG Ratio

-0.37

Profit Margin

Operating Margin

Return on Assets (ttm)

-30.0

Return on Equity (ttm)

-168.9

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-6.957

Qtrly Earnings Growth

Operating Cash Flow (M)

-287.69

Levered Free Cash Flow (M)

-177.41

FoxReading.com

Valuation

P/E

-5.75

P/E Growth Ratio

-0.02

P/BV

40.22

P/S

P/CF

-9.17

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.